glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Hemolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dooley, A; Hamilton, G; Heitz, J; Kidane, AG; Olbrich, M; Punshon, G; Ramesh, B; Salacinski, HJ; Seifalian, AM | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Hemolysis
Article | Year |
---|---|
Incorporation of a lauric acid-conjugated GRGDS peptide directly into the matrix of a poly(carbonate-urea)urethane polymer for use in cardiovascular bypass graft applications.
Topics: Blood Platelets; Cardiovascular Diseases; Cell Adhesion; Cell Shape; Cells, Cultured; Endothelial Cells; Hemolysis; Humans; Lauric Acids; Microscopy, Electron, Scanning; Myocardial Revascularization; Oligopeptides; Polymers; Polyurethanes; Solubility; Spectroscopy, Fourier Transform Infrared | 2006 |